Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 Jun;59(6):483–487. doi: 10.1136/thx.2003.017640

NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

A Agusti, M Morla, J Sauleda, C Saus, X Busquets
PMCID: PMC1747038  PMID: 15170030

Abstract

Background: Weight loss, mostly due to skeletal muscle atrophy, is a frequent and clinically relevant problem in patients with chronic obstructive pulmonary disease (COPD). The molecular mechanisms underlying this phenomenon are unclear. This study sought to investigate whether activation of the nuclear transcription factor NF-κB and upregulation of the inducible form of nitric oxide synthase (iNOS) occur in the skeletal muscle of patients with COPD and low body weight as potential molecular mechanisms leading to cachexia

Methods: NF-κB DNA binding activity was determined by electromobility shift assay and the immunoreactivity of its inhibitory subunit IκB-κ and that of iNOS by Western blot analysis in biopsy specimens of the quadriceps femoris muscle of seven COPD patients with normal body mass index (BMI, 27.5 (1) kg/m2) and seven patients with low BMI (18.5 (1) kg/m2).

Results: Compared with patients with normal body weight, those with low BMI showed a 30% increase in NF-κB DNA binding activity, a lower expression of IκB-α (3.37 (0.47) IOD v 5.96 (0.75) IOD, p<0.05; mean difference 2.59; 95% CI –4.53 to –0.65) and higher iNOS expression (1.51 (0.29) IOD v 0.78 (0.11) IOD, p<0.05; mean difference 0.74; 95% CI 0.04 to 1.42).

Conclusions: NF-κB activation and iNOS induction occur in skeletal muscle of COPD patients with low body weight. These changes might contribute to the molecular pathogenesis of cachexia in COPD.

Full Text

The Full Text of this article is available as a PDF (179.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams Volker, Späte Ulrike, Kränkel Nicolle, Schulze Paul Christian, Linke Axel, Schuler Gerhard, Hambrecht Rainer. Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase. Eur J Cardiovasc Prev Rehabil. 2003 Aug;10(4):273–277. doi: 10.1097/00149831-200308000-00009. [DOI] [PubMed] [Google Scholar]
  2. Agustí A. G. N., Noguera A., Sauleda J., Sala E., Pons J., Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003 Feb;21(2):347–360. doi: 10.1183/09031936.03.00405703. [DOI] [PubMed] [Google Scholar]
  3. Agustí Alvar G. N., Sauleda Jaume, Miralles Cristina, Gomez Cristina, Togores Bernat, Sala Ernest, Batle Santiago, Busquets Xavier. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002 Aug 15;166(4):485–489. doi: 10.1164/rccm.2108013. [DOI] [PubMed] [Google Scholar]
  4. Asano K., Chee C. B., Gaston B., Lilly C. M., Gerard C., Drazen J. M., Stamler J. S. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10089–10093. doi: 10.1073/pnas.91.21.10089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barnes P. J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997 Apr 10;336(15):1066–1071. doi: 10.1056/NEJM199704103361506. [DOI] [PubMed] [Google Scholar]
  6. Barreiro Esther, Comtois Alain S., Gea Joaquin, Laubach Victor E., Hussain Sabah N. A. Protein tyrosine nitration in the ventilatory muscles: role of nitric oxide synthases. Am J Respir Cell Mol Biol. 2002 Apr;26(4):438–446. doi: 10.1165/ajrcmb.26.4.4634. [DOI] [PubMed] [Google Scholar]
  7. Barreiro Esther, Gea Joaquim, Corominas Josep M., Hussain Sabah N. A. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2003 Jun 19;29(6):771–778. doi: 10.1165/rcmb.2003-0138OC. [DOI] [PubMed] [Google Scholar]
  8. Bernard S., LeBlanc P., Whittom F., Carrier G., Jobin J., Belleau R., Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Aug;158(2):629–634. doi: 10.1164/ajrccm.158.2.9711023. [DOI] [PubMed] [Google Scholar]
  9. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  10. Brüne B., von Knethen A., Sandau K. B. Nitric oxide and its role in apoptosis. Eur J Pharmacol. 1998 Jun 26;351(3):261–272. doi: 10.1016/s0014-2999(98)00274-x. [DOI] [PubMed] [Google Scholar]
  11. Debigaré R., Côté C. H., Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1712–1717. doi: 10.1164/ajrccm.164.9.2104035. [DOI] [PubMed] [Google Scholar]
  12. Espat N. J., Copeland E. M., Moldawer L. L. Tumor necrosis factor and cachexia: a current perspective. Surg Oncol. 1994 Oct;3(5):255–262. doi: 10.1016/0960-7404(94)90027-2. [DOI] [PubMed] [Google Scholar]
  13. Frandsen U., Lopez-Figueroa M., Hellsten Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun. 1996 Oct 3;227(1):88–93. doi: 10.1006/bbrc.1996.1472. [DOI] [PubMed] [Google Scholar]
  14. Guttridge D. C., Mayo M. W., Madrid L. V., Wang C. Y., Baldwin A. S., Jr NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000 Sep 29;289(5488):2363–2366. doi: 10.1126/science.289.5488.2363. [DOI] [PubMed] [Google Scholar]
  15. Hart L. A., Krishnan V. L., Adcock I. M., Barnes P. J., Chung K. F. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1585–1592. doi: 10.1164/ajrccm.158.5.9706116. [DOI] [PubMed] [Google Scholar]
  16. Lanone S., Mebazaa A., Heymes C., Henin D., Poderoso J. J., Panis Y., Zedda C., Billiar T., Payen D., Aubier M. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med. 2000 Dec;162(6):2308–2315. doi: 10.1164/ajrccm.162.6.2001097. [DOI] [PubMed] [Google Scholar]
  17. Lanone Sophie, Manivet Philippe, Callebert Jacques, Launay Jean-Marie, Payen Didier, Aubier Michel, Boczkowski Jorge, Mebazaa Alexandre. Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity. Biochem J. 2002 Sep 1;366(Pt 2):399–404. doi: 10.1042/BJ20020339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mackiewicz Z., Hukkanen M., Povilenaite D., Sukura A., Fonseca J. E., Virtanen I., Konttinen Y. T. Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies. Clin Exp Rheumatol. 2003 Jan-Feb;21(1):41–48. [PubMed] [Google Scholar]
  19. Miralles C., Busquets X., Santos C., Togores B., Hussain S., Rahman I., MacNee W., Agustí A. G. Regulation of iNOS expression and glutathione levels in rat liver by oxygen tension. FEBS Lett. 2000 Jul 7;476(3):253–257. doi: 10.1016/s0014-5793(00)01748-8. [DOI] [PubMed] [Google Scholar]
  20. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  21. Mostert R., Goris A., Weling-Scheepers C., Wouters E. F., Schols A. M. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000 Sep;94(9):859–867. doi: 10.1053/rmed.2000.0829. [DOI] [PubMed] [Google Scholar]
  22. Reid M. B. COPD as a muscle disease. Am J Respir Crit Care Med. 2001 Oct 1;164(7):1101–1102. doi: 10.1164/ajrccm.164.7.2108039a. [DOI] [PubMed] [Google Scholar]
  23. Reid M. B. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand. 1998 Mar;162(3):401–409. doi: 10.1046/j.1365-201X.1998.0303f.x. [DOI] [PubMed] [Google Scholar]
  24. Roca J., Sanchis J., Agusti-Vidal A., Segarra F., Navajas D., Rodriguez-Roisin R., Casan P., Sans S. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir. 1986 May-Jun;22(3):217–224. [PubMed] [Google Scholar]
  25. Sauleda J., García-Palmer F., Wiesner R. J., Tarraga S., Harting I., Tomás P., Gómez C., Saus C., Palou A., Agustí A. G. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1413–1417. doi: 10.1164/ajrccm.157.5.9710039. [DOI] [PubMed] [Google Scholar]
  26. Schols A. M., Buurman W. A., Staal van den Brekel A. J., Dentener M. A., Wouters E. F. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996 Aug;51(8):819–824. doi: 10.1136/thx.51.8.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schols A. M., Slangen J., Volovics L., Wouters E. F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1791–1797. doi: 10.1164/ajrccm.157.6.9705017. [DOI] [PubMed] [Google Scholar]
  28. Schols A. M., Soeters P. B., Dingemans A. M., Mostert R., Frantzen P. J., Wouters E. F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993 May;147(5):1151–1156. doi: 10.1164/ajrccm/147.5.1151. [DOI] [PubMed] [Google Scholar]
  29. Sridhar M. K. Why do patients with emphysema lose weight? Lancet. 1995 May 13;345(8959):1190–1191. doi: 10.1016/s0140-6736(95)91984-8. [DOI] [PubMed] [Google Scholar]
  30. Staal F. J., Roederer M., Herzenberg L. A., Herzenberg L. A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9943–9947. doi: 10.1073/pnas.87.24.9943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wang W. W., Jenkinson C. P., Griscavage J. M., Kern R. M., Arabolos N. S., Byrns R. E., Cederbaum S. D., Ignarro L. J. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun. 1995 May 25;210(3):1009–1016. doi: 10.1006/bbrc.1995.1757. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES